Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study

Yong Xiang Gwee, Andrea Li Ann Wong, Boon Cher Goh, Ross Andrew Soo, Wei Peng Yong, David Shao Peng Tan, Cheng Ean Chee, Siew Eng Lim, Yvonne Ang, Yiqing Huang, Wan Qin Chong, Joline Lim, Gloria Chan, Natalie Ngoi, Samuel Ow, Rachel Wong, Kenneth Sooi, Joan Choo, Soo Chin Lee

Open source

DOI: 10.3389/fonc.2026.1948986
Published: 2026-10-16
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1948986,
  title = {Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study},
  author = {Yong Xiang Gwee and Andrea Li Ann Wong and Boon Cher Goh and Ross Andrew Soo and Wei Peng Yong and David Shao Peng Tan and Cheng Ean Chee and Siew Eng Lim and Yvonne Ang and Yiqing Huang and Wan Qin Chong and Joline Lim and Gloria Chan and Natalie Ngoi and Samuel Ow and Rachel Wong and Kenneth Sooi and Joan Choo and Soo Chin Lee},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1948986},
  url = {https://doi.org/10.3389/fonc.2026.1948986}
}

RIS

TY  - JOUR
TI  - Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study
AU  - Yong Xiang Gwee
AU  - Andrea Li Ann Wong
AU  - Boon Cher Goh
AU  - Ross Andrew Soo
AU  - Wei Peng Yong
AU  - David Shao Peng Tan
AU  - Cheng Ean Chee
AU  - Siew Eng Lim
AU  - Yvonne Ang
AU  - Yiqing Huang
AU  - Wan Qin Chong
AU  - Joline Lim
AU  - Gloria Chan
AU  - Natalie Ngoi
AU  - Samuel Ow
AU  - Rachel Wong
AU  - Kenneth Sooi
AU  - Joan Choo
AU  - Soo Chin Lee
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1948986
UR  - https://doi.org/10.3389/fonc.2026.1948986
ER  -

APA

Gwee, Y. X., Wong, A. L. A., Goh, B. C., Soo, R. A., Yong, W. P., Tan, D. S. P., Chee, C. E., Lim, S. E., Ang, Y., Huang, Y., Chong, W. Q., Lim, J., Chan, G., Ngoi, N., Ow, S., Wong, R., Sooi, K., Choo, J., & Lee, S. C. (2026). Prospective evaluation of combination oral S-1 and intravenous cisplatin in cancer patients with severe hepatic dysfunction – a feasibility, safety, and pharmacokinetic study. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1948986

Source records

crossref · retrieved 2026-11-10T15:00:00.958Z